Dr. Zannatun Noor
Deputy Project Coordinator and Assistant Scientist,
International Centre for Diarrhoeal Disease Research, Bangladesh
zannatun@icddrb.org
Member since 2021

Short Biography

Zannatun Noor is an early career research female scientist at icddr,b. She completed her PhD at University of Virginia, USA on 2016 and completed a thesis entitled “Mucosal immunology against amebic colitis”. In 2019, she has received two prestigious research awards, namely: Emerging Global Leader Award from Fogarty, NIH and Thrasher Early Career award.

Currently, her current research focused on child nutrition and child enteric infection. In her 5 years NIH grant project she is looking host defense against Shigella flexneri, one of the most important problems in enteric infections. The innovative aspect of her study is the ability to analyze the colonic tissue response during acute infection and upon convalescence from S. flexneri infection in humans. In addition, her Thrasher awarded research grant she is studying for an effective treatment of Cryptosporidiosis in Bangladeshi children. She is conducting a randomized study in the Mirpur slum area, where cryptosporidium infected children will receive Nitazoxanide treatment with or without the probiotic, Lactobacillus reuteri DSM 17938. She has also received a Transformer fund from IsDB to study enteric infection, malnutrition, and environmental enteropathy status of Rohingya children in Bangladesh. She serves as section Editor for Current tropical Medicine Reports on 2015-2016.

Selected Publications

  1. Watanabe K, Gilchrist CA, Uddin MJ, Burgess SL, Abhyankar MM, Moonah SN, Noor Z, Donowitz JR, Schneider BN, Arju T, Ahmed E, Kabir M, Alam M, Haque R, Pramoonjago P, Mehrad B, Petri WA Jr. Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis. PLoSPathog. 2017 Aug 17;13(8):e1006513.
  2. Noor Z, Watanabe K, Abhyankar MM, Burgess SL, Buonomo EL, Cowardin CA, Petri WA Jr. Role of Eosinophils and Tumor Necrosis Factor Alpha in Interleukin-25-Mediated Protection from Amebic Colitis. mBio. 2017 Feb 28;8(1):e02329-16.
  3. Abhyankar MM, Noor Z, Tomai MA, Elvecrog J, Fox CB, Petri WA Jr. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica. Vaccine. 2017 Feb 7;35(6):916-922.
  4. Cowardin CA, Jackman BM, Noor Z, Burgess SL, Feig AL, Petri WA Jr. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A. Infect Immun. 2016 Jul 21;84(8):2317-2323.

Noor Z, Burgess SL, Watanabe K, Petri WA Jr. Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent. PLoS One. 2016 Apr 18;11(4):e0153572.